Skip to content

Clinical trials

Carcinoma, Hepatocellular trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Country / region: Netherlands Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20092
20102
20111
20122
20133
20152
20162
20174
20184
20192
20201
20216
20224
20234
20243
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Recruiting13
Terminated5
Unknown status5
Active, not recruiting4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Erasmus Medical Center3
Exelixis3
UMC Utrecht3
Bayer2
Bristol-Myers Squibb2
Daiichi Sankyo2
Hoffmann-La Roche2
Leiden University Medical Center2
Merck Sharp & Dohme LLC2
Radboud University Medical Center2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular50
Liver Neoplasms11
Neoplasms6
Squamous Cell Carcinoma of Head and Neck6
Stomach Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Colorectal Neoplasms5
Carcinoma, Renal Cell4
Carcinoma, Transitional Cell4
Cholangiocarcinoma4

Trials

Showing 76 to 50 of 50. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.